OpenAlex
PricingAboutJobs
Log inGet started
Work

Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials

HTML

Year: 2012
Type: article
Source: Alzheimer s & Dementia
DOI: 10.1016/j.jalz.2011.11.002
Authors: Jesse M. Cedarbaum, Mark Jaros, Chito Hernandez, Nicola Coley, Sandrine Andrieu, Michael Grundman, Bruno Vellas, Alzheimer's Disease Neuroimaging Initiative
Institutions: Cytokinetics (United States), Elan Pharmaceuticals, Inc. (Ireland), Université Toulouse III - Paul Sabatier, Inserm, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse
Language: English

Topic: Dementia and Cognitive Impairment Research
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: CDR-SB, Alzheimer's disease
SDG: Good health and well-being

Open Access status: closed

Funders: Merck, Elan, National Institutes of Health, National Institute on Aging
OpenAlex ID: W2130240223
FWCI: 4.641
Cites: 36
Cited by: 160
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security